| API |
Grade |
CAS No. |
Documentation |
Regulatory Approvals |
| Anti-Histamine / Anti-Cholinergic |
| Buclizine HCl |
BP |
129-74-8 |
eCTD DMF |
COFEPRIS, WHO GMP, MHRA,HPRA, EU-WC, Portugal,Israel, Malta, MOH-Taiwan |
| Cinnarizine |
EP, BP, IP |
298-57-7 |
eCTD DMF, CEP |
EU-GMP, COFEPRIS, WHO GMP,EU-WC, IDL(China), MOH(Russia), MOH-Taiwan |
| Cyclizine HCl |
EP, BP, USP |
82-92-8 |
eCTD DMF |
WHO GMP, EU-WC, South Africa |
| Cyproheptadine HCl |
EP,BP,USP, IP |
41354-29-4 |
eCTD DMF |
COFEPRIS, WHO GMP,IDL(China), EU- WC, MOH-Taiwan, |
| Meclizine HCl |
EP, BP, USP |
31884-77-2 |
eCTD DMF, JDMF, CEP |
EDQM, PMDA Japan, WHO GMP, EU-WC, COFEPRIS, MEB-Netherland, MOH-Taiwan, ANVISA,CADIFA (U/R) |
| Flunarizine HCl |
EP, BP |
30484-77-6 |
eCTD DMF, CEP |
EDQM, COFEPRIS, WHO GMP, EU-WC, MOH-Taiwan, ANVISA |
| Hydroxyzine HCl |
USP, EP, IP |
2192-20-3 |
Ectd DMF, CEP(U/R), US DMF (U/R) |
WHO GMP, EU-WC |
| Hydroxyzine Pamoate |
USP |
68-88-2 |
Techpack |
|
| Muscle relaxant / Pain Management |
| Carisoprodol |
EP, USP, IP |
78-44-4 |
eCTD DMF |
ANVISA, COFEPRIS, WHO GMP, EU-WC, MOH (Taiwan) |
| Etodolac |
EP, USP, IP |
41340-25-4 |
eCTD DMF, CEP |
EDQM, WHO-GMP, EU-WC, ANVISA,CADIFA (U/R) |
| Pentoxifylline |
EP, USP |
06-05-6493 |
eCTD DMF |
WHO GMP, EU-WC, IDL (China) (U/R) |
| Cilostazol |
USP |
73963-72-1 |
DMF |
GMP. |
| Anti-Diarrheal |
| Loperamide HCl |
EP, BP, USP |
34552-83-5 |
eCTD DMF, CEP |
WHO GMP, COFEPRIS, MOH(Russia), EU-WC, EDQM, MOH-Taiwan |
| Prostaglandins |
| Bimatoprost |
IH |
155206-00-1 |
eCTD DMF |
WHO-GMP, EU-WC |
| Misoprostol |
USP |
59122-46-2 |
Tech Pack |
GMP |
| Cardiovascular |
| Diltiazem HCl |
EP, USP, IP |
33286-22-5 |
eCTD DMF, CEP |
WHO GMP,EU- WC, KFDA (U/R) |
| Anesthetic |
| Prilocaine |
EP |
721-50-6 |
Tech pack |
None |
| Propofol |
USP, EP |
2078-54-8 |
Tech pack |
None |
